课题基金 / 基金详情

Consequences of Dynamin 2 PH Domain Dysfunction in Charcot-Marie-Tooth Neuropathy

Consequences of Dynamin 2 PH Domain Dysfunction in Charcot-Marie-Tooth Neuropathy
Dynamin 2 PH 结构域功能障碍对腓骨肌神经病的影响
批准号:
nhmrc : 372104
负责人:
Prof Adam Mccluskey
金额:
$44.36万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31

项目摘要

项目成果

Prof Adam Mccluskey的其他基金

相似基金

相关文献

中文摘要
翻译
我们的团队刚刚发现了一种新的基因突变,它会导致CMT病。CMT是一种临床和遗传多样化的人类周围神经病变家族。CMT神经病变是最常见的遗传性周围神经病变,约1 / 2500。它是已知的最常见的人类遗传疾病,由50个或更多的基因引起。CMT具有重大的经济意义,因为许多受影响的个人领取终身无效养恤金,需要持续的医疗和辅助医疗支助。我们发现的新突变是CMT的一种变体形式,它影响了一个叫做PH结构域的重要区域的蛋白动力蛋白2。Dyn2的正常功能是从细胞膜上回收激活的激素和生长因子受体(呼叫者受体介导的内吞作用或RME),它也需要其他功能,如细胞增殖。PH结构域是Dyn2的一部分,它允许它在需要完成工作时移动到细胞的适当部分,但目前尚不清楚突变是否会破坏Dyn2的这一功能。由于Dyn2具有多种细胞功能,目前尚不清楚它为什么会导致这种疾病。我们的目标是通过揭示动力蛋白的哪些功能主要受到影响,来理解为什么这种突变会导致周围神经退化。我们希望揭示RME与神经元退化之间的联系的新概念。在之前的研究中,我们开发了第一种与PH结构域相互作用的药物。我们现在将充分开发这些药物,并合成与PH结构域相互作用的新药,作为修复受损PH结构域的候选药物。更好地了解Dyn2和内吞作用对于理解CMT和最终开发治疗方法至关重要。
英文摘要
Our team has just discovered a new gene mutation that causes Charcot-Marie-Tooth (CMT) disease. CMT is a clinically and genetically diverse family of human peripheral neuropathies. CMT neuropathy is the most common inherited peripheral neuropathy, affecting approximately 1 in 2500. It is the most common human genetic disorder known and is caused by fifty or more genes. CMT is of large economic significance since many of the affected individuals are on lifetime invalid pensions and require continual medical and paramedical support. The new mutation we discovered is in a variant form of CMT and affects the protein dynamin 2, in an important region called the PH domain. The normal function of Dyn2 is to retrieve activated receptors for hormones and growth factors from the membrane of cells (caller receptor mediated endocytosis or RME) and it is also required for other functions like cell proliferation. The PH domain is the part of Dyn2 that allows it to move to the appropriate part of the cell when needed to do its job, but it is not known whether the mutation disrupts this function of Dyn2. Since Dyn2 has multiple cellular functions, it is not understood why it might cause the disease. Our goal is to understand why this mutation causes peripheral nerves to degenerate, by revealing which of dynamin's many functions are primarily affected. We expect to uncover a new concept in how RME links to neuronal degeneration. In previous studies we developed the first drugs that interact with PH domains. We will now fully develop these, and synthesise new drugs that interact with the PH domain, as candidates to effect some repair of the damaged PH domain. A better understanding of Dyn2 and endocytosis is crucial to understanding both CMT and ultimately for developing therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Simultaneous targeting of contraception and sexually transmitted disease
  • 批准号:
    nhmrc : 1066326
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.43万
  • 财政年份:
    2014
  • 负责人:
    Prof Adam Mccluskey
  • 依托单位:
Mechanism of action of dynamin ring stabilizer compounds controlling the actin cytoskeleton
  • 批准号:
    nhmrc : 1032771
  • 项目类别:
    Project Grants
  • 资助金额:
    $43.97万
  • 财政年份:
    2012
  • 负责人:
    Prof Adam Mccluskey
  • 依托单位:
Sulfonadyn-based dynamin I-specific inhibitors and epilepsy
  • 批准号:
    nhmrc : 1011457
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $55.7万
  • 财政年份:
    2011
  • 负责人:
    Prof Adam Mccluskey
  • 依托单位:
Development of dynamin inhibitors as novel therapies for epilepsy
  • 批准号:
    nhmrc : 571076
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $60.24万
  • 财政年份:
    2009
  • 负责人:
    Prof Adam Mccluskey
  • 依托单位:
国内基金
海外基金
circRNA Rims2通过miR-30b/140调节毛细胞突触蛋白Dynamin在老年性聋发病中的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    胡娅琴
  • 依托单位:
Dynamin 1调控神经内分泌细胞囊泡亚量子化分泌的分子机理研究
  • 批准号:
    82000757
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    张泉峰
  • 依托单位:
神经元钙粘蛋白Celsr1通过调控Dynamin-1在抑郁发作中的作用及其机制研究
  • 批准号:
    LY19H090024
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2018
  • 负责人:
    戴云坚
  • 依托单位:
lncRNA-Malat1介导miR-30b/140调节内毛细胞突触蛋白Dynamin的机制研究
  • 批准号:
    81873702
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    袁伟
  • 依托单位: